Premier Press Release Services Newswire Service Reimagined: Reach more investors, media and customers with precision targeting.
United States
Joined June 2016
- Tweets43.6K
- Following2.8K
- Followers6.7K
- Likes16.4K
$ALOY The Pentagon's Rare Earth Deadline Is Almost Here. Is Anyone Ready? finance.yahoo.com/energy/art…
$SPYR SPYR (OTC: SPYR) completes Ledjr AI change of control, appoints Mohammed Siddiqi CEO and outlines audit, SEC registration and corporate rebranding plans prismmediawire.com/spyr-inc-…
🤖 Made with AI
ALT SPYR, Inc. (OTC: SPYR) completed its change of control with Ledjr AI, appointing Mohammed Siddiqi CEO and director. The company targets completing an audit and filing an SEC registration statement within 90 days and is preparing a name and ticker change. Reported liabilities declined from approximately $28.6 million to $722,000 following court-supervised restoration
@prism_mediawire is proud to announce the official Digital Media Partnership with @VostockCapital_ and @LatinVostock for the coverage of the 5th Anniversary International Congress Syngas Nitrogen Uzbekistan and CIS syngasuz.com/en/media-partne… Press: prismmediawire.com/5th-anniv…
🤖 Made with AI
ALT The 5th Anniversary International Congress Nitrogen & Syngas Uzbekistan & CIS 2026 will bring together 200+ industry executives, 40+ speakers and 15+ investment projects in Tashkent on November 18–19, 2026. Organized by Vostock Capital, the event will explore ammonia, methanol, mineral fertilizers, syngas processing, AI, Industry 4.0, production efficiency, environmental modernization and investment opportunities across Uzbekistan and the CIS.
PRISM MediaWire retweeted
PRISM Mid-Day Movers: Cybersecurity and Healthcare are Today’s Leaders.
BIO-key International (NASDAQ: $BKYI ) shares rose roughly 28% to $2.6950, gaining $0.5950 per share, by midday.
Lucid Diagnostics (NASDAQ: $LUCD ) shares rose almost 26% to $0.3858, gaining $0.0581 per share. The advance followed news that the company began receiving Medicare reimbursement for its EsoGuard test and closed a $15 million financing.
Other Notable Movers:
Quantum-Si Inc. ($QSI) up 13%
CalciMedica ($CALC) up 11%
SHF Holdings, Inc. ($SHFS ) down -48%
Stock prices and percentage changes are as of 12:00 p.m. ET on October 23, 2026, and are subject to change.
prismmarketview.com/prism-mi…
PRISM MediaWire retweeted
$CRLBF
Cresco Labs opened Sunnyside Prestonsburg in Kentucky, the company’s 83rd dispensary nationwide.
→ Per the company, dispensaries are now operating in all 11 regions of Kentucky’s medical cannabis program for the first time
→ Medical program only, in Eastern Kentucky; CEO Charlie Bachtell calls the opening a step toward improving patient access
Caveats: no sales, patient volume, or financial impact disclosed. State-licensed medical cannabis; Cresco trades on the CSE and OTCQX.
prismmarketview.com/companie…
PRISM MediaWire retweeted
Evaxion ($EVAX) reported three-year phase 2 data for EVX-01, its personalized cancer vaccine in advanced melanoma: 89% of the vaccine's targets generated tumor-specific T-cell responses, up from 86% at two years.
Each patient gets a vaccine designed from their own tumor. Six of the 12 responders kept taking EVX-01 alone for a third year, and all maintained their response with no tumor progression.
The trial enrolled 16 patients. The data goes to ESMO on Oct. 24.
prismmarketview.com/evaxion-…
PRISM MediaWire retweeted
$BLRX
BioLineRx and Hemispherian presented preclinical data at ESMO 2026 suggesting GLIX1 can extend the activity of PARP inhibitors in HR-proficient ovarian cancer, tumors that tend to be less sensitive to these drugs.
→ Lab: GLIX1 enhanced olaparib, veliparib, and niraparib across several HR-proficient cell lines (ZIP synergy scores 10.9 to 43.2)
→ 28-day mouse study using patient-derived tumor tissue: low-dose GLIX1 plus olaparib significantly slowed tumor growth vs. vehicle, with growth inhibition comparable to cisplatin in that model
→ BioLineRx plans to add an ovarian cancer arm during the expansion phase of its ongoing GLIX1 trial (no start date given)
prismmarketview.com/bioliner…
PRISM MediaWire retweeted
Join us October 23–24 at the InterContinental Hotel Cleveland as surgical leaders come together to explore the latest techniques and advances in single-port robotic surgery. We look forward to connecting with you in Cleveland!
#BioStemTechnologies $BSEM #ClevelandClinic #RoboticSurgery #SinglePortSurgery #SurgicalInnovation #PlacentalTissue #MedTech
PRISM MediaWire retweeted
October is National Physical Therapy Month, and this year’s “PT For Future Me” theme is about strength and mobility for life, not just recovery.
Five public companies are working on different stages of it:
$KIDS: pediatric orthopedics, where lifelong mobility starts
$OMDA: a physical therapist-designed exercise plan that helped GLP-1 users lose more weight while gaining muscle
$ENOV: braces, recovery tools and joint replacements, from injury to rehab
$MYO: the MyoPro powered arm brace, restoring function after stroke and injury
$FIGS: outfitting the professionals who make it all work prismmarketview.com/national… #PTForFutureMe
PRISM MediaWire retweeted
$MIRA said oral MIRA-55 delivered pain relief comparable to Celebrex in a 21-day preclinical chronic inflammatory pain study, with no tolerance observed. The data support a planned IND submission.
prismmarketview.com/companie…
PRISM MediaWire retweeted
$BCTX
BriaCell presented an ESMO 2026 poster on a blood-based immune biomarker in metastatic breast cancer: PD-L1 on circulating cancer-associated macrophage-like cells (CAMLs). In a pooled analysis of 111 patients, post-treatment measurements were associated with outcomes, while the pretreatment measurement was not.
→ At ~37 days: significantly associated with progression-free survival
→ At ~3 months: significantly associated with both progression-free and overall survival
→ Pooled patients received different checkpoint inhibitors, some with the Bria-IMT regimen; 60% had triple-negative disease
prismmarketview.com/briacell…
PRISM MediaWire retweeted
Lucid Diagnostics ($LUCD) began receiving Medicare payments for its EsoGuard esophageal DNA test at the established fee schedule rate of $1,938.01 per test. It also closed a $15M Series C preferred placement with existing shareholders.
Payments are coming in for tests run at its Texas lab. Noteholders in the deal said the payments addressed the concerns behind a Medicare-related default provision in its 2029 convertible notes.
California lab claims still await a final revised coverage determination, and the Series C converts at $0.3519 with a 20% dividend paid in stock.
prismmarketview.com/lucid-di…
PRISM MediaWire retweeted
$SKYX
@skyxplatforms Corp. and its subsidiary Deako announced plans to supply more than 80,000 units of plug-and-play and smart-home technologies for more than 1,000 Maronda Homes residences, with deliveries expected in 2027.
→ Projects span several states, including Ohio, Georgia, Maryland, and Pennsylvania
→ Maronda is a privately held builder founded in 1972 with 70,000+ homes built, active in 11 states
→ Deako’s CEO describes the program as a model for other builder relationships
prismmarketview.com/skyx-and…
PRISM MediaWire retweeted
🔐 BIO-key $BKYI jumped 30.5% to $2.74 and is up again premarket after winning its 7th Gulf government customer in 6 months.
A national security institution is deploying PortalGuard, Passkey:YOU and EcoID III.
It's leading the PRISM Cybersecurity Index 👇
prismmarketview.com/bio-key-…
We’ve received several comments about AI agents in press release distribution and crawling, so we asked our COO, who has been serving clients for more than 15 years, for his comments.
The Past: Clients were satisfied when press releases appeared on Yahoo Finance, Seeking Alpha, Benzinga, and similar outlets. Journalists and media outlets took note of incoming emails and newsletters, then began covering a story if they were interested. AI ecosystems weren’t discussed because they simply didn’t exist yet.
The Present: Press releases now need to be visible to both humans and machines. AI agents are becoming more prevalent, but visibility on financial and brokerage sites remains important.
The Future: AI agents will work for journalists and media organizations, crawl news, and deliver it to specific dashboards. Traditional media channel displays will be less important than they were in the past and are today.
PRISM MediaWire retweeted
$DMAC enrolled the 200th patient in its Phase 2/3 ReMEDy2 acute ischemic stroke trial of DM199, reaching the threshold for a planned interim analysis. Results are expected in Q1 2027.
prismmarketview.com/companie…
PRISM MediaWire retweeted
PRISM M☀️RNING M☀️VERS
Premarket Gainers:
J-Star Holding Co., Ltd. ($YMAT) - up 62%
WISeSat.Space Holdings Corp. ($SAIQ) - up 26%
RingCentral, Inc. ($RNG) - up 15%
BIO-key International, Inc. ($BKYI) - up 12%
Premarket Decliners:
Davion Healthcare Plc Ordinary Shares ($DAVI) - down 40%
Tantech Holdings Ltd ($TANH) - down 38%
Stock prices and percentage changes are as of 8:30 a.m. ET on October 23, 2026, and are subject to change.
Socket Full of Sunshine Act calls for first federal-level support for US plug-in solar pv-tech.org/socket-full-of-s…
Balcony solar laws classify the technology as household appliances solarpowerworldonline.com/20…
PRISM MediaWire retweeted
$FUBO signed seven new regional sports network deals for the 2026-27 NBA season, covering teams including the Hawks, Pistons, HEAT, Bucks and Thunder. Its NBA RSN market coverage now tops 75%.
prismmarketview.com/companie…
